Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene for Psychotic Symptoms in Women with Schizophrenia
NCT00361543Phase 4Completed
- Sponsor
- Alfred Health
- Start
- Aug 2006
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia, schizoaffective disorder and schizophreniform disorder comparing Raloxifene + Antipsychotic with Placebo + Antipsychotic (2 arms). Primary endpoint: Positive and Negative Syndrome Scale at 12 weeks. Started Aug 2006; status: completed.
02
Drugs
raloxifene
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NCT00361543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00361543.